Navigation Links
Chem Rx Corporation Surpasses 67,000 Beds Served
Date:7/1/2008

- Exhibits Growth In All Existing Markets -

LONG BEACH, N.Y., July 1 /PRNewswire-FirstCall/ -- Chem Rx Corporation (OTC Bulletin Board: CHRX, CHRXU, CHRXW), a leading provider of institutional pharmacy services, today announced that it has surpassed 67,000 beds served, a five percent increase over the past six months. The Company experienced growth across all five of its institutional facilities including Long Beach, Albany, Pennsylvania, New Jersey and Florida.

Steven C. Silva, President and Chief Operating Officer, commented, "We are very pleased with the progress we have made during the first half of the year which is a testament to our high quality of service and strong reputation in the marketplace. Achieving the 67,000 bed milestone was solely attributable to strong organic growth in each of our existing regions. In addition, we have expanded in the Florida marketplace and are adding beds after commencing operations just three months ago. We expect to continue to demonstrate organic growth for the remainder of the year."

About Chem Rx

Founded more than 40 years ago, Chem Rx is a major institutional pharmacy serving the New York City metropolitan area, as well as parts of New Jersey, upstate New York, Pennsylvania and Florida. Chem Rx's client base includes skilled nursing facilities and a wide range of other long-term care facilities. Chem Rx annually provides over six million prescriptions to more than 67,000 residents of more than 425 institutional facilities. Chem Rx's website address is http://www.chemrx.net.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about Chem Rx Corporation. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are based upon the current beliefs and expectations of Chem Rx's management and are subject to risks and uncertainties that could cause actual results to differ from the forward-looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: compliance with government regulations; changes in legislation or regulatory environments; requirements or changes adversely affecting the health care industry, including changes in Medicare reimbursement policies; fluctuations in customer demand; management of rapid growth; intensity of competition; timing, approval and market acceptance of new product introductions and institutional pharmacy locations; general economic conditions; geopolitical events and regulatory changes, as well as other relevant risks detailed in Chem Rx Corporation's filings with the SEC. The information set forth herein should be read in light of such risks. Chem Rx Corporation does not assume any obligation to update the information contained in this press release.
Contacts:

Steven Silva Stephanie Carrington/Jared Hoffman

President and Chief Operating Officer The Ruth Group

Chem Rx 646-536-7017 / 7013

investors@chemrx.net scarrington@theruthgroup.com

jhoffman@theruthgroup.com


'/>"/>
SOURCE Chem Rx Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Air Methods Corporation Confirms Mid-Air Collision in Arizona
2. Vystar Corporation Announces Agreement with Kildare Capital to Provide Investment Banking Services
3. Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardiovascular Tests
4. Oregon Based First Pacific Corporation Launches New E-Tools Program for Dentists
5. CRH Medical Corporation opens Center in San Diego California
6. uKarma Corporation Commences International Distribution Agreement With Northern Response for its Xflowsion DVD Series
7. Zix Corporation Processes More Than 20 Million Electronic Prescriptions
8. Chem Rx Corporation Appoints Gary M. Jacobs Chief Financial Officer
9. Digirad Corporation to Present at CapStone Small-Cap Investor Conference
10. Insulet Corporation to Present at the William Blair & Company 28th Annual Growth Stock Conference on June 19, 2008
11. Harris Corporations Jim Traficant Addresses Florida Agency for Health Care Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... ... May 28, 2016 , ... "Color Grading media can be time consuming but ... their media," said Christina Austin - CEO of Pixel Film Studios. , With ... add stylish color grades to their footage. A LUT is a Lookup Table that ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... More than ... so it is not surprising that bariatric surgery has received increased attention in recent ... explains. Of course, when it comes to weight loss, most people are familiar with ...
(Date:5/27/2016)... ... ... An influential resource amongst nurses and professionals in the health care world, ... of topics detailing why we appreciate nurses in so many different ways. From exclusive ... being in a major recession to one of the hottest growing professions in any ...
(Date:5/27/2016)... ... May 27, 2016 , ... In ... the many who are unaware of the plight of aphasia. In collaboration with ... the “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively ...
(Date:5/27/2016)... ... May 27, 2016 , ... Each year ... complementary medicine. Allison Outerbridge is this year’s Life University winner of ... at the university’s Student Leadership Awards ceremony. , Outerbridge is approaching her last ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 2016 Since its commercial introduction ... essential life science tool for conducting genetic studies in ... reveals in its new report that the industry sits ... powered by a range of new applications in the ... http://photos.prnewswire.com/prnh/20140723/694805 ) , Since the ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 /PRNewswire/ ... Frankfurt Prime Standard: QIA) today announced that the company has ... GmbH to develop and commercialize predictive assays in oncology. An ... a marker to predict effectiveness of anthracycline treatment in triple ... are pleased to partner with Therawis, which developed the PITX2 ...
(Date:5/25/2016)... Florida , May 25, 2016 ... Conference & Expo earlier this month, the numbers and ... revenues continue to climb into the billions, more research ... newly released 4th Edition State of Legal Marijuana Markets ... a cannabis-focused data-analysis firm, much of the increase in ...
Breaking Medicine Technology: